You can also find out more about availing of Cromos Pharma’s special programs including:
Free Feasibility Reports for Sponsors considering expanding their clinical trials into Central and Eastern Europe. You confidentially provide us with your protocol, synopsis, or trial outline and in just two weeks our expert team will deliver a detailed feasibility report including:
“No Patients - No Payment” is Cromos Pharma’s proprietary risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met. Simply put, if we don’t recruit – you don’t pay.
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic areas. Our expert team, comprising 95% MDs, has expansive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in studies from biosimilars and generics to successfully managing oncology, neurology, and dermatology clinical trials. Our team provides full-service solutions to international pharma and biotech in high-recruiting regions, assuring exceptional quality data. Cromos Pharma combines global expertise, with in-depth experience and knowledge, in Central and Eastern Europe to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of trials conducted.
We provide accelerated study start-up timelines in our regions of operation. We regularly achieve regulatory approvals in Georgia within two months of project signing (four months in Russia, and in less than five months in Ukraine). Regulatory inspections and site audits also attest to the highest quality of our clinical data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA.
Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021). A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum.